Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | PPM1B | O75688 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL764832 | 1.00 | TP53 (0.48) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL14424491 | 1.00 | TP53 (0.48) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 | |
| Hydrochloric Acid SCHEMBL27278187 | 0.98 | TP53 (0.47) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL12220653 | 0.93 | TP53 (0.48) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL27025580 | 0.91 | SMN1; SMN2 (0.49) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL2200767 | 0.89 | TP53 (0.56) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL2948892 | 0.89 | TP53 (0.56) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL74396 | 0.89 | TP53 (0.56) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 | |
| SCHEMBL244740 | 0.89 | — | — | |
| SCHEMBL30901182 | 0.89 | SMN1; SMN2 (0.55) | TP53SMN1; SMN2CHRNB2CHRNA4CHRNB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119161372-A | Bimetallic compound based on hydrazide pyrene skeleton, and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-116410098-A | Preparation method for synthesizing alpha-aminoketone compound from fatty aldehyde and secondary amine | 西北工业大学 | 2023-07-11 | — | — | CN | claimed |
| US-20140030609-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND ENERGY STORAGE DEVICE USING SAME | UBE INDUSTRIES, LTD. (JP) | 2014-01-30 | — | — | US | claimed |
| US-4157435-A | TITANIUM, ALUMINUM, SILOXANE COORDINATION CATALYST | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-06-05 | — | — | US | claimed |
| CN-122079745-A | Efficient and energy-saving separation method for 1, 4-Cyclohexanedimethanol (CHDM) | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4192833-B1 | PHARMACOLOGICALLY ACTIVE HETEROCYCLIC-SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES | RICHTER GEDEON NYRT (HU) | 2026-01-21 | — | — | EP | disclosed |
| US-12473293-B2 | Pharmacologically active heterocyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives | RICHTER GEDEON NYRT. (HU) | 2025-11-18 | — | — | US | disclosed |
| CN-114790480-B | Primer probe and kit for detecting MMACHC gene mutation site | 苏州淦江生物技术有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119161372-A | Bimetallic compound based on hydrazide pyrene skeleton, and preparation method and application thereof | 万华化学集团股份有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-118206428-A | Continuous preparation method and system of 1, 4-cyclohexanedimethanol and preparation method of Ni/Cu catalyst | 上海戊正工程技术有限公司 | 2024-06-18 | — | — | CN | disclosed |
| EP-3490974-B1 | SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | TENACIA BIOTECHNOLOGY HONG KONG CO LTD (HK) | 2023-12-06 | — | — | EP | disclosed |
| US-20230295145-A1 | PYRROLIDINE DERIVATIVES AND METHODS OF USE | GENENTECH INC (US) | 2023-09-21 | — | — | US | disclosed |
| CN-1223631-A | Process for the preparation of cyclohexanedimethanol | NEW JAPAN CHEM CO LTD (JP) | 1999-07-21 | — | — | CN | disclosed |
| EP-0922690-A1 | PROCESS FOR THE PREPARATION OF CYCLOHEXANEDIMETHANOL | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1999-06-16 | — | — | EP | disclosed |
| CN-1216522-A | Therapeutic agent for diabetes | JAPAN TOBACCO INC (JP) | 1999-05-12 | — | — | CN | disclosed |
| EP-0885869-A1 | THERAPEUTIC AGENT FOR DIABETES | Japan Tobacco Inc. (JP) | 1998-12-23 | — | — | EP | disclosed |
| CN-1099744-A | Low pressure process for the manufacture of cyclohexanedicarboxylate esters | EASTMAN CHEM CO (US) | 1995-03-08 | — | — | CN | disclosed |
| US-4507290-A | CONTRACEPTIVE | WORLD HEALTH ORGANIZATION (CH) | 1985-03-26 | — | — | US | disclosed |
| US-4157435-A | TITANIUM, ALUMINUM, SILOXANE COORDINATION CATALYST | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-06-05 | — | — | US | disclosed |
| US-4085276-A | CATALYST COMPOSED OF AN ORGANOMETALLIC COMPOUND AND THE REACTION PRODUCT OF A MAGNESIUM COMPOUND AND A TITANIUM COMPOUND | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JA) | 1978-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295145-A1 | PYRROLIDINE DERIVATIVES AND METHODS OF USE | DPYD, TP53, GLS | TP53 2/4885SMN1; SMN2 2183/4885CHRNB2 4708/4885 |
| US-12473293-B2 | Pharmacologically active heterocyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives | GABRA5, GABRA1, P2RX5 | TP53 3362/4885SMN1; SMN2 2384/4885CHRNB2 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.